These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 1668919)

  • 1. [The role of the tumor necrosis factor in the pathogenesis of infectious-inflammatory endotoxicosis].
    Povzun SA
    Vestn Khir Im I I Grek; 1991; 147(7-8):127-32. PubMed ID: 1668919
    [No Abstract]   [Full Text] [Related]  

  • 2. The role of tumor necrosis factor in systemic inflammatory responses in primate endotoxemia.
    van der Poll T; Levi M; ten Cate H; van Deventer SJ
    Prog Clin Biol Res; 1994; 388():425-33. PubMed ID: 7831375
    [No Abstract]   [Full Text] [Related]  

  • 3. [Tumor necrosis factor or cachectin].
    Marcheş F
    Rev Roum Virol; 1991; 42(1-2):97-104. PubMed ID: 1790126
    [No Abstract]   [Full Text] [Related]  

  • 4. Cachectin/TNF mediates the pathophysiological effects of bacterial endotoxin/lipopolysaccharide (LPS).
    Tracey KJ; Lowry SF; Cerami A
    Prog Clin Biol Res; 1988; 272():77-88. PubMed ID: 3293084
    [No Abstract]   [Full Text] [Related]  

  • 5. Tumor necrosis factor.
    Oettgen HF; Old LJ
    Important Adv Oncol; 1987; ():105-30. PubMed ID: 2841229
    [No Abstract]   [Full Text] [Related]  

  • 6. Role of tumor necrosis factor-alpha in the pathogenesis of glomerular diseases.
    Egido J; Gómez-Chiarri M; Ortíz A; Bustos C; Alonso J; Gómez-Guerrero C; Gómez-Garre D; López-Armada MJ; Plaza J; Gonzalez E
    Kidney Int Suppl; 1993 Jan; 39():S59-64. PubMed ID: 8385721
    [No Abstract]   [Full Text] [Related]  

  • 7. Lymphotoxin and tumour necrosis factor as possible mediators of an inflammatory response.
    Ciba Found Symp; 1987; 131():185-91. PubMed ID: 3330010
    [No Abstract]   [Full Text] [Related]  

  • 8. Clinical trials with human tumor necrosis factor: in vivo and in vitro effects on human mononuclear phagocyte function.
    Conkling PR; Chua CC; Nadler P; Greenberg CS; Doty E; Misukonis MA; Haney AF; Bast RC; Weinberg JB
    Cancer Res; 1988 Oct; 48(19):5604-9. PubMed ID: 3046744
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tumor necrosis factor-related apoptosis-inducing ligand pathway and its therapeutic implications.
    de Vries EG; Gietema JA; de Jong S
    Clin Cancer Res; 2006 Apr; 12(8):2390-3. PubMed ID: 16638843
    [No Abstract]   [Full Text] [Related]  

  • 10. Acute inflammation and microthrombosis induced by endotoxin, interleukin-1, and tumor necrosis factor and their implication in gram-negative infection.
    Cybulsky MI; Chan MK; Movat HZ
    Lab Invest; 1988 Apr; 58(4):365-78. PubMed ID: 3282123
    [No Abstract]   [Full Text] [Related]  

  • 11. Role of the pro-inflammatory cytokines tumor necrosis factor-alpha, interleukin-1 beta, interleukin-6 and interleukin-8 in the pathogenesis of the otitis media with effusion.
    Smirnova MG; Kiselev SL; Gnuchev NV; Birchall JP; Pearson JP
    Eur Cytokine Netw; 2002; 13(2):161-72. PubMed ID: 12101072
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tumor necrosis factor: a plurifunctional mediator of acute inflammation.
    Warren JS; Ward PA; Johnson KJ
    Mod Pathol; 1988 May; 1(3):242-7. PubMed ID: 2853361
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Tumor necrosis factor induces acute phase proteins in rats.
    Gresser I; Delers F; Tran Quangs N; Marion S; Engler R; Maury C; Soria C; Soria J; Fiers W; Tavernier J
    J Biol Regul Homeost Agents; 1987; 1(4):173-6. PubMed ID: 2459907
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Role of tissue factor in the antitumor effect of recombinant human tumor necrosis factor-alpha in mice.
    Nishigaki F; Miyayasu K; Tsujimoto S; Manda T; Shimomura K
    Anticancer Res; 1994; 14(6B):2573-6. PubMed ID: 7872683
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Tumor necrosis factor: how to improve the antitumor activity and decrease accompanying side effects for therapeutic application.
    Haranaka K
    J Biol Response Mod; 1988 Dec; 7(6):525-34. PubMed ID: 3063778
    [No Abstract]   [Full Text] [Related]  

  • 16. Tumor necrosis factor and interleukin-1: role in acute inflammation and microvascular injury.
    Movat HZ
    J Lab Clin Med; 1987 Dec; 110(6):668-81. PubMed ID: 3316455
    [No Abstract]   [Full Text] [Related]  

  • 17. Biology of tumor necrosis factor-alpha- implications for psoriasis.
    Schottelius AJ; Moldawer LL; Dinarello CA; Asadullah K; Sterry W; Edwards CK
    Exp Dermatol; 2004 Apr; 13(4):193-222. PubMed ID: 15086336
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The inflammatory response in Mycobacterium tuberculosis infection.
    Toossi Z
    Arch Immunol Ther Exp (Warsz); 2000; 48(6):513-9. PubMed ID: 11197606
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Transient increase of plasma interleukin-6 after infusion of recombinant tumor necrosis factor alpha in advanced cancer patients.
    Zubelewicz B; Romanowski W; Braczkowska B; Lissoni P; Braczkowski R
    J Exp Clin Cancer Res; 1998 Dec; 17(4):449-52. PubMed ID: 10089067
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Role of tumor necrosis factor in Crohn's disease.
    Ganesan S; Travis SP; Ahmad T; Jazrawi R
    Curr Opin Investig Drugs; 2002 Sep; 3(9):1297-300. PubMed ID: 12498003
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.